Visceral pleural invasion (VPI) has been known to be an adverse prognostic factor in non-small cell lung cancer (NSCLC). However, the prognostic significance of extent of VPI (PL0, PL1 and PL2) remains controversial. We conduct a meta-analysis to summarize available evidence on this topic. PubMed, EMBASE, OVID and The Cochrane Library were searched for published studies from inception to May 9, 2016. A total of 16 studies were included in meta-analysis. Our results showed that patients with PL1 or PL2 had poorer overall survival compared with PL0 (HR = Lung cancer is the leading cause of cancer death worldwide. Visceral pleural invasion (VPI), since 1970s, has been adopted as a T descriptor in the TNM classification and known to be an adverse prognostic factor in non-small cell lung cancer (NSCLC) [1][2][3] . The 7th edition TNM staging system of lung cancer recommended the classification of pleural invasion as PL0 if the tumor does not invade past the elastic layer, as PL1 if it invades past the elastic layer, PL2 if it invades to the pleural surface and PL3 if it invades to the parietal pleura 4 . PL1 and PL2 were defined as VPI and PL0 was defined as without VPI.1However, the International Association for the Study of Lung Cancer (IASLC) team didn't analysis and validate the prognosis of PL status in the 7th TMN classification of lung cancer because of insufficient data to be submitted 3 . Most studies investigated the prognostic value of VPI without distinguishing the extent of VPI (PL1 and PL2) [5][6][7][8][9][10] . It is still unclear whether PL1 and PL2 are equivalent and whether they should be combined to define VPI, or how tumors with PL1 and PL2 should be classified. Recently, Chan YL and associates reported resected NSCLC patients with PL2 had significant worse survival than those with PL1 and suggested PL2 to be a potential indication for adjuvant chemotherapy 11 . Likewise, Hung J. J. et al. reported patients with PL2 had significantly worse overall survival and lower probability of freedom from recurrence than those with PL1 after resection of node-negative NSCLC 12 . And some other studies also reached positive results [13][14][15] . Contrary to the studies mentioned above, there were some other studies that didn't find the survival difference between PL1 and PL2 patients [16][17][18][19][20][21][22][23][24] . Thus, the evidence on this topic remains controversial. Our previously study has demonstrated that VPI is a consistent adverse prognostic factor in stage I NSCLC patients 25 . In this study, we focused on the prognostic significance of PL0, PL1 and PL2 and aimed to answer the question whether PL2 has worse prognosis than PL1 in resected NSCLC patients.